Why is Jagsonpal Pharma falling/rising?

As of 28-Jul, Jagsonpal Pharmaceuticals Ltd is experiencing a significant rise in its stock price, currently at Rs 292.55, reflecting an increase of Rs 26.55 or 9.98%. The stock has shown strong performance today, outperforming its sector by 9.9% and has gained 15.84% over the last two days. It opened with a gain of 3.38% and reached an intraday high of Rs 301.8. Over the past week, the stock has increased by 17.63%, and in the last month, it has risen by 32.95%. The company has demonstrated healthy long-term growth, with operating profit increasing at an annual rate of 42.15%, and it has reported positive results for the last five consecutive quarters, contributing to investor confidence.
In the broader market context, while the Sensex has declined by 1.59% over the past week, Jagsonpal Pharmaceuticals has significantly outperformed this benchmark, highlighting its strong market position. The stock's year-to-date performance shows a gain of 19.67%, contrasting with the Sensex's modest increase of 3.52%. This strong performance is further supported by a low debt-to-equity ratio and a high debtors turnover ratio, indicating financial stability. The rising investor participation, evidenced by a 207% increase in delivery volume, also suggests growing confidence in the stock, reinforcing its upward momentum in a challenging market environment.